Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16Novartis Pharmaceuticals Corporation

02 4Novartis South Africa (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2019-05-24

Application Number : 212526

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date : 2019-05-24

Application Number : 212526

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 2019-05-24

Application Number : 212526

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : VIJOICE

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-04-05

Application Number : 215039

Regulatory Info : RX

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : VIJOICE

Dosage Form : TABLET;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2022-04-05

Application Number : 215039

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : VIJOICE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 2022-04-05

Application Number : 215039

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : VIJOICE

Dosage Form : GRANULES;ORAL

Dosage Strength : 50MG/PACKET

Packaging :

Approval Date : 2024-04-24

Application Number : 218466

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Alpelisibum

Brand Name : Piqray

Dosage Form : Film-Coated Tablets

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Alpelisibum

Brand Name : Piqray

Dosage Form : Film-Coated Tablets

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Alpelisibum

Brand Name : Piqray

Dosage Form : Filmtabl

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Alpelisibum

Brand Name : Piqray

Dosage Form : Filmtabl

Dosage Strength : 200mg+50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Alpelisibum

Brand Name : Piqray

Dosage Form : Filmtabl

Dosage Strength : 200mg+50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : TABLET

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 2497069

Regulatory Info : Prescription

Registration Country : Canada

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : TABLET

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number : 2497077

Regulatory Info : Prescription

Registration Country : Canada

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : KIT

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2497085

Regulatory Info : Prescription

Registration Country : Canada

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALPELISIB

Brand Name : PIQRAY

Dosage Form : KIT

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number : 2497085

Regulatory Info : Prescription

Registration Country : Canada

blank

17

Novartis South Africa (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Alpelisib

Brand Name : PIVIKTO 200

Dosage Form : FCT

Dosage Strength : 200mg

Packaging : 56 X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

18

Novartis South Africa (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Alpelisib

Brand Name : PIVIKTO 50

Dosage Form : FCT

Dosage Strength : 50mg

Packaging : 56 X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

19

Novartis South Africa (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Alpelisib

Brand Name : PIVIKTO 150mg

Dosage Form : FCT

Dosage Strength : 150mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

20

Novartis South Africa (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Alpelisib

Brand Name : PIVIKTO 200mg

Dosage Form : FCT

Dosage Strength : 200mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank